Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.520
+0.040 (2.70%)
At close: Dec 20, 2024, 4:00 PM
1.510
-0.010 (-0.66%)
After-hours: Dec 20, 2024, 6:36 PM EST
Coherus BioSciences Employees
Coherus BioSciences had 306 employees as of December 31, 2023. The number of employees decreased by 53 or -14.76% compared to the previous year.
Employees
306
Change (1Y)
-53
Growth (1Y)
-14.76%
Revenue / Employee
$994,575
Profits / Employee
-$1,471
Market Cap
175.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Lyell Immunopharma | 224 |
Sight Sciences | 214 |
Molecular Partners AG | 168 |
Genfit | 159 |
Nektar Therapeutics | 137 |
BrainsWay | 134 |
MediWound | 100 |
CHRS News
- 3 days ago - Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025 - GlobeNewsWire
- 5 days ago - Coherus BioSciences: Shedding Pegfilgrastim To Fuel Ongoing Development - Seeking Alpha
- 18 days ago - Why Is Coherus BioSciences Stock Trading Higher On Tuesday? - Benzinga
- 24 days ago - Coherus Management to Participate in the 2024 Citi Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Coherus BioSciences, Inc. (CHRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 4 months ago - Evaluating Coherus BioSciences: Udenyca's Success And Loqtorzi's Prospects - Seeking Alpha